Felsenrose PhNT

When tradition meets science

This project focuses on the development of a standardized plant extract derived from Mediterranean species with a longstanding ethnopharmacological use in the modulation of nervous system activity and cognitive attention.

In brief

El TDAH y el TEA comórbido con TDAH representan un desafío significativo para quienes lo padecen y sus familias. Los medicamentos sintéticos suelen estar asociados con efectos secundarios que dificultan su uso prolongado. Nuestro proyecto de investigación ofrece una alternativa natural prometedora: basándonos en estudios etnobotánicos y etnofarmacológicos, estamos desarrollando un extracto vegetal utilizado tradicionalmente en niños con dificultades de concentración.

The project

Our project focuses on the development of an innovative plant extract, primarily derived from Cistus albidus and complemented with other Mediterranean species such as rosemary (and Rosmarinus officinalis) and hawthorn (Crataegus monogyna), among others. This unique formula was discovered through an ethnobotanical study, and its efficacy has been confirmed and further explored through ethnopharmacological research.

Preliminary Results

Nuestros resultados son alentadores: el extracto fue descrito como altamente efectivo en niños con los síntomas típicos de hiperactividad. Estos niños lograron mejorar su capacidad de concentración, se distraían menos, estaban más tranquilos y mostraban una reducción en la irritabilidad y la agresividad. Análisis sugieren que estos efectos se deben al sinergismo de compuestos como los polifenoles, los terpenos y otros compuestos vegetales con propiedades farmacológicas.

The potential

Our studies indicate that the extract acts on several key aspects related to ADHD and ASD+ADHD: mitochondrial dysfunction, alterations in gut function, neuroimmune dysregulation, and dysregulation of monoaminergic systems.

The next level

To transform this promising discovery into an effective, safe, and accessible alternative, securing the necessary resources is essential. These will enable the initiation of critical clinical phases required to obtain approval from the European Medicines Agency (EMA) and ensure that this natural treatment reaches those who most need it.

Join us and help take this natural alternative to the next level!

Collaborate

Collaborate
Collaborate
This website uses cookies of its own and third - for correct operation and for analytical purposes. Contains links to third-party websites with privacy policies, which you can accept or not when you run them. By clicking the Accept button, you agree to the use of these technologies and the processing of your data for these purposes.
Privacy